CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

CRO Services

As your Contract Research Organization, OXON helps plan and implement the generation of Real-World evidence for safety, market access/HEOR and drug development.

KNOW MORE

Late-phase studies 

We help pharmaceutical, biotech and  medical device companies to cost-effectively meet the requirements of late-phase clinical studies for better outcomes or greater value.

KNOW MORE

Therapeutic Areas

OXON offers proven experience and a large portfolio of studies in all major therapy areas, including orphan conditions, pregnancy, and risk minimization.

KNOW MORE

Real World Evidence and Late-Phase Research

OXON has been selected as a preferred provider by several big pharma companies.
With strong links to EMA and world-renowned academics and institutions in Europe and Asia for studies and teaching, OXON offers proven experience and a large portfolio of studies in all major therapeutic areas

READ ABOUT US

OXON conducts:

• Primary data studies: prospective, registries, retrospective chart review, cross-sectional, surveys and pragmatic trials
• Secondary data studies: electronic records and registries
• Hybrid studies, including external controls for orphan medicines
• Synthesis research: systematic review and aggregate and IPD meta-analysis and landscaping
• Data analysis, modelling and simulation

World Class Science

Our specialization and high calibre allow us to have clear focus, deep expertise and superior insight to provide concrete results with maximum value to our clients.

Global Reach

We are specialised in multi-country observational studies and provide real-world evidence services worldwide with the expertise and multi-language capabilities of local partners. 

Strong Links

OXON’s services are reinforced with academic links with the London School of Hygiene & Tropical Medicine and with leading academic methodological and clinical consultants.

Long Term Alliances

OXON’s alliances provide global geographical local country operational support, allowing us to compete on a global scale in performing studies projects on both sides of the Atlantic.

Newsroom

Read about us, our latest news and events 

SUSCRIBE TO OUR NEWS

Free Live Online Masterclass on RWE & Trials with Professor Stuart Pocock

Free Live Online Masterclass on RWE & Trials with Professor Stuart Pocock “External Controls for Trials: Strategy, Science, Regulators & HTAs” DATE: Tuesday, 11 June 2024, at 5pm CEST |[…]

Read more

FREE LIVE ONLINE WEBINAR SERIES ON RWE 2024-2025: the UK

‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of the UK Next session of the Free Live Online Webinar Series on RWE hosted by OXON   Date: Wednesday, 26 June[…]

Read more
16th Clinical Trials Strategic Summit (CTSS)

OXON sponsors the 16th Clinical Trials Strategic Summit (CTSS)

OXON is proud to be a Gold Sponsor at the 16th Clinical Trials Strategic Summit (CTSS)  May 28-29, 2024 | Munich Marriott Hotel | Munich, Germany The 16th Clinical Trials[…]

Read more

We strive our best to support our clients in conducting cost-efficient observational studies worldwide

We pulled together 
professionals and resources to serve you better

READ MORE

Let us help design and conduct your optimal PASS or Outcomes observational study

OXON IS YOUR RWE OBSERVATIONAL STUDIES SERVICE PROVIDER

OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, >600 papers (100+ NEJM/Lancets)

REQUEST A MEETING

We are a partner centre of the ENCePP scientific network, which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the EU PAS Register, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies

Contact us! It will only take a minute

CONTACT US